http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0098179-A3

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-948
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-809
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-08
filingDate 1983-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1985-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0098179-A3
titleOfInvention Hybridoma cell lines and monoclonal antibodies to theophylline
priorityDate 1982-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0077896-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0044441-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2805961-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415006318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2153

Total number of triples: 23.